Immunoscintigraphy with 99mTc-14F7 and 99mTc-Nimotuzumab in patients with non-small cell lung cancer

Abstract

The immunoscintigraphy is a non-invasive technique with high specificity. The technique provides information on the location of the tumor and its metastases, detects specific biomarkers on the cell surface of tumors, characterizing it by establishing its biology and phenotype. It also evaluates the response to the treatment that is applied, and allows performing a personalized targeted therapy.The authors show the imagines of two patients with non-small cell lung cancer after administration of the 99m Tc-14F7 and 99m Tc-Nimotuzumab. The tumors showed high expression of specific antigens.